Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11732051-B2 United States of America 22 Aug 2023
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia Grant US-11713355-B2 United States of America 01 Aug 2023
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11708419-B2 United States of America 25 Jul 2023
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11708420-B2 United States of America 25 Jul 2023
Methods of treating high risk multiple myeloma Grant US-11618787-B2 United States of America 04 Apr 2023
Subcutaneous formulations of anti-CD38 antibodies and their uses Grant US-11566079-B2 United States of America 31 Jan 2023
SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES Grant EP-3827845-B1 European Patent Office 30 Mar 2022
STABLE LIQUID PHARMACEUTICAL PREPARATION Application EP-3824904-A4 European Patent Office 25 Aug 2021
ANTI-HER2 ANTIBODY DRUGS FOR SUBCUTANEOUS INJECTION Application RU-2750821-C2 Russian Federation 05 Jul 2021
SUBCUTANEOUSLY ADMINISTERED BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF CANCER Grant EP-3177645-B1 European Patent Office 17 Feb 2021
SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES Grant EP-3370770-B1 European Patent Office 20 Jan 2021
SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS Application WO-2018136412-A3 World Intellectual Property Organisation (WIPO) 15 Nov 2018